NewsRoom Articles - Page 1312 of 1352

TuesdayDec 06, 2016 12:37 pm

Cellceutix Corp. (CTIX) Advances Pipeline toward Multi-billion Dollar Opportunities, Piques Peer Interest along the Way

Cellceutix (OTCQB: CTIX) CEO Leo Ehrlich in September issued a fiscal year-end business statement recapping the company’s ability to usher its three unique compounds through various stages of clinical trials to successfully meet primary endpoints and drop anchors in several key markets. Advancements of its current pipeline – spanning dermatology, cancer, infectious disease and gastrointestinal indications – also set the company on course to achieve another season of remarkable progress. Cellceutix’s lead cancer drug candidate is Kevetrin™, an Orphan Drug anti-cancer agent entering phase 2a clinical trials for the treatment of ovarian cancer. Upon commercialization, Kevetrin would be the world’s…

TuesdayDec 06, 2016 12:30 pm

Citius Pharmaceuticals (CTXR) Starts Presentation at LD Micro Main Event

Citius Pharmaceuticals (OTC: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products. The company has a focus on anti-infectives, cancer care and unique prescription products using innovative, patented or proprietary formulations of previously approved active pharmaceutical ingredients. By using previously approved drugs with substantial safety and efficacy data, the company seeks to reduce the risks associated with pharmaceutical product development and regulatory requirements, and focuses on developing products that have intellectual property protection and competitive advantages to existing therapeutic approaches. For more information, visit the company's website at www.citiuspharma.com. About NetworkNewsWire NetworkNewsWire (NNW)…

TuesdayDec 06, 2016 12:30 pm

New Age Beverages (NBEV) Starts Presentation at LD Micro Main Event

New Age Beverages (OTC: NBEV) is a healthy functional beverage company originally founded in 2003, which in 2016 re-created via the combination of XingTea®, Aspen Pure® Artesian Water, Búcha® Live Kombucha, and New Age Beverages. The company competes in several segments, including ready to drink (RTD) tea, RTD coffee, kombucha, energy drinks, relaxation drinks and functional waters. The company's portfolio also includes Marley One Drop® RTD Coffee and Marley Mellow Mood™ Relaxation Drinks. The brands are sold in 46 states within the U.S. and in more than 10 countries internationally across all channels via direct and store door distribution systems.…

TuesdayDec 06, 2016 12:30 pm

BioCorRx (BICX) Starts Presentation at LD Micro Main Event

BioCorRx (OTC: BICX) is a healthcare solutions company focused on improving the lives of those struggling with alcohol and opioid addiction. Designed to treat alcoholism and certain opioid addictions, the BioCorRx® Recovery Program is used by a network of independently owned and operated treatment centers located throughout the United States. The program consists of a proprietary long-lasting implant of the FDA approved medication, naltrexone, which is proven to substantially reduce cravings for drugs and alcohol. It is a high-quality, comprehensive and cost- effective recovery program built on a strong foundation of experience and practice, allowing for an improved quality of…

TuesdayDec 06, 2016 12:30 pm

Lightbridge (LTBR) Starts Presentation at LD Micro Main Event

Lightbridge (NASDAQ: LTBR) is a nuclear fuel technology company that operates in two segments: technology and consulting. The company offers all-metal fuel for operating and new build reactors; all-uranium seed and blanket fuel for existing plants and new build reactors; and thorium-based seed and blanket fuel for existing and new build reactors. The company's services include integrated strategic advice across a range of areas, including regulatory development, nuclear reactor site selection, procurement and deployment, reactor and fuel technology, international relations, program management, regulatory affairs, and infrastructure development. For more information, visit the company website at www.ltbridge.com. About NetworkNewsWire NetworkNewsWire (NNW)…

TuesdayDec 06, 2016 12:30 pm

Hemispherx Biopharma (HEB) Starts Presentation at LD Micro Main Event

Hemispherx Biopharma (NYSE: HEB) is an advanced specialty pharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of seriously debilitating disorders. The company's flagship products include Alferon N Injection® and the experimental therapeutics Rintatolimod (tradenames Ampligen® or Rintamod®) and Alferon® LDO. Rintatolimod is an experimental RNA nucleic acid being developed for globally important debilitating diseases and disorders of the immune system, including Chronic Fatigue Syndrome. Hemispherx's platform technology includes components for potential treatment of various severely debilitating and life threatening diseases. For more information, visit the company's website at www.hemispherx.net. About NetworkNewsWire NetworkNewsWire (NNW)…

TuesdayDec 06, 2016 12:00 pm

Spotlight Innovation (STLT) Starts Presentation at LD Micro Main Event

Spotlight Innovation (OTC: STLT) identifies and acquires rights to innovative, proprietary technologies designed to address unmet medical needs, with an emphasis on rare, emerging and neglected diseases. To find and evaluate unique opportunities, the company leverages its extensive relationships with leading scientists, academic institutions and other sources. Spotlight Innovation provides value-added development capability to accelerate development progress. For more information, visit the company's website at www.spotlightinnovation.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of…

TuesdayDec 06, 2016 12:00 pm

Issuer Direct (ISDR) Starts Presentation at LD Micro Main Event

Issuer Direct (NYSE: ISDR) is a tech company that provides disclosure management solutions, shareholder communications tools, and cloud-based compliance technologies. The company offers products and services that enable businesses to produce and distribute their financial and business communications online and in print. It also provides disclosure management system, a cloud-based business process reporting and automation solution that enables users the ability to disclose, manage, and communicate their respective messages from its enterprise platform. For more information, visit the company website at www.issuerdirect.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of…

TuesdayDec 06, 2016 12:00 pm

Onconova Therapeutics (ONTX) Starts Presentation at LD Micro Main Event

Onconova Therapeutics (NASDAQ: ONTX) is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a proprietary chemistry platform, the company has created an extensive library of targeted anti-cancer agents designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. Onconova has three product candidates in clinical trials and several active pre-clinical programs. Advanced clinical trials with its lead compound, rigosertib, are aimed at unmet medical needs of patients with myelodysplastic syndromes (MDS). For more information, visit the company's website at www.onconova.com.…

TuesdayDec 06, 2016 12:00 pm

Advanced Medical Isotope (ADMD) Starts Presentation at LD Micro Main Event

Advanced Medical Isotope (OTC: ADMD) is a late-stage development company primarily engaged in the development of brachytherapy devices for therapeutic applications. The company's focus is on transitioning to full operations upon receipt, if any, of FDA clearance for its patented brachytherapy cancer products. Brachytherapy uses radiation to destroy cancerous tumors by placing a radioactive isotope inside or next to the treatment area. For more information, visit the company's website at www.isotopeworld.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company…